BLCO · Bausch & Lomb Corp
$16.28
+0.09 (+0.56%)
At close · Jul 27
Market Cap
$5.80B
Shares
356.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brenton L. Saunders | CEO | $32,194,326 |
| Sam Eldessouky | CFO | $4,962,441 |
| A. Robert D. Bailey | Executive Vice President and Chief Legal Officer | $3,632,951 |
| Yehia Hashad | Head of R&D and Chief Medical Officer | $2,789,501 |
| Andrew Stewart | President of Global Pharmaceuticals and International Consumer | $2,500,253 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brenton L. Saunders | CEO | $23,860,756 |
| Sam Eldessouky | CFO | $6,840,989 |
| A. Robert D. Bailey | Executive Vice President and Chief Legal Officer | $5,528,579 |
| Yehia Hashad | Head of R&D and Chief Medical Officer | $4,526,091 |
| Dr. Yehia Hashad | Executive Vice President of Research & Development and Chief Medical Officer | $4,526,091 |
| Andrew Stewart | President of Global Pharmaceuticals and International Consumer | $4,082,270 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Brenton L. Saunders | CEO | $45,309,051 |
| A. Robert D. Bailey | Executive Vice President and Chief Legal Officer | $5,214,599 |
| Sam Eldessouky | CFO | $4,757,166 |
| Yehia Hashad | Head of R&D and Chief Medical Officer | $2,657,494 |
| Dr. Yehia Hashad | Executive Vice President of Research & Development and Chief Medical Officer | $2,657,494 |
| Andrew Stewart | President of Global Pharmaceuticals and International Consumer | $1,933,266 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Papa | CEO | $19,781,761 |
| Sam Eldessouky | CFO | $6,152,073 |
| Christina M. Ackermann | General Counsel | $4,735,526 |
| Joseph Gordon | President, Global Consumer, Surgical and Vision Care | $3,998,623 |
| Dr. Yehia Hashad | Executive Vice President of Research & Development and Chief Medical Officer | $2,852,793 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Papa | CEO | $22,889,137 |
| Christina M. Ackermann | General Counsel | $4,574,588 |
| Sam Eldessouky | CFO | $4,332,224 |
| Joseph Gordon | President, Global Consumer, Surgical and Vision Care | $3,240,526 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Papa | CEO | $14,119,361 |
| Christina M. Ackermann | General Counsel | $3,541,028 |
| Joseph Gordon | President, Global Consumer, Surgical and Vision Care | $2,207,854 |
| Sam Eldessouky | CFO | $1,318,165 |
Key facts
CIK
1860742
CUSIP
071705107
13F (30d)
10 filings
10 filers
Visit website
Investor relations